Ticker: MTD

Mettler Toledo

Healthcare Healthcare Medical - Diagnostics & Research

Price 1280.24

Reco Sell Potential 40 Risk 70 Updated 2026-09-10

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Mettler Toledo is a global manufacturer of precision instruments and analytical solutions, primarily serving the healthcare, food, and chemical industries. The company specializes in laboratory instruments, industrial scales, and retail weighing solutions. Major business segments include Laboratory, Industrial, and Food Retail, with revenue primarily generated from the sale of instruments, software, and services. Mettler Toledo's products are essential for quality control and regulatory compliance in various sectors.

Investment Profile

Mettler Toledo's stock is more aligned with balanced investors due to its stable revenue streams and established market position. While it does not offer dividends, the company's focus on precision instruments positions it for moderate growth potential. The investment profile suggests a medium to long-term horizon, appealing to those seeking a combination of capital appreciation and stability.

Category: Healthcare Sector: Healthcare Industry: Medical - Diagnostics & Research Investment style: Growth Horizon: Long-term Company type: Blue Chip Company type: Market Leader

Fundamental metrics (experimental) Updated: 2026-09-08

EPS (TTM) — earnings per share for the last 12 months, $: 44.51
Revenue QoQ — quarter-over-quarter revenue growth: 8.5%
EPS surprise: 6.3%
20d volatility: 0.9%

AI recommendation changes

Date	Before	After	Reason
2026-09-10	Hold	Sell	Weak momentum and high risk; hold for now.
2026-09-05	Buy	Hold	Weak momentum and high risk; cautious approach advised.
2026-07-29	Hold	Buy	Strong momentum, but revenue decline raises concerns.
2026-07-17	Sell	Hold	Weak revenue growth raises concerns despite positive EPS surprise.
2026-07-09	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-06-27	Sell	Hold	Weak fundamentals and mixed momentum signal caution.
2026-05-30	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-05-08	—	Hold	Mixed performance; high risk with uncertain momentum.
2026-05-07	Hold	Buy	Компания показывает стабильный рост выручки и положительное значение EPS, однако недавние падения на более длительных горизонтах вызывают опасения. Рекомендуется удерживать акции до получения более ясных сигналов о восст
2026-04-18	Buy	Hold	Компания демонстрирует стабильный рост выручки и положительный сюрприз по EPS, однако недавние колебания цен и негативная динамика на более длительных сроках вызывают осторожность.
2026-04-09	Hold	Buy	Компания показывает стабильный рост выручки и положительные результаты по EPS, однако недавнее снижение на 60 дней вызывает опасения. Рекомендуется удерживать акции до дальнейших сигналов о восстановлении.
2026-03-03	Buy	Hold	Компания демонстрирует стабильный рост выручки, однако недавние колебания цен и снижение на коротких временных интервалах могут указывать на неопределенность. Рекомендуется удерживать акции до более ясных сигналов о восс
2026-02-22	Hold	Buy	Компания показывает умеренный рост выручки и положительную динамику за последние 120 дней, однако недавнее снижение цен акций на 4.21% за 20 дней вызывает осторожность.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-09-01	RBC Capital	Update	— → 1515	1405.14
2026-08-04	Morgan Stanley	Target Raised	1275 → 1450	1433.89001
2026-08-03	Barclays	Target Raised	1300 → 1575	1416.3
2026-08-03	Stifel Nicolaus	Target Raised	— → 1600	1416.3
2026-07-31	Jefferies	Target Raised	1400 → 1580	1412.91
2026-07-06	Evercore ISI	Target Raised	1300 → 1350	1292.73999
2026-05-18	Stifel Nicolaus	Target Lowered	1600 → 1400	1031.64
2026-05-11	Robert W. Baird	Target Lowered	1445 → 1194	1124.46
2026-04-14	Barclays	Target Lowered	1550 → 1500	1345.89
2026-02-09	Morgan Stanley	Target Lowered	— → 1475	1382.72
2026-02-09	Robert W. Baird	Target Raised	1444 → 1445	1373.57
2025-12-15	Wells Fargo	Target Raised	1400 → 1450	1393.64001
2025-12-15	Susquehanna	Update	— → 1600	1393.64001
2025-12-15	Barclays	Target Lowered	1600 → 1550	1393.64001
2025-12-09	Goldman Sachs	Update	— → 1475	1381.37
2025-12-01	Morgan Stanley	Update	— → 1550	1468.09

News Page 1 of 1

Nothing yet